InvestorsHub Logo
Followers 58
Posts 10053
Boards Moderated 1
Alias Born 09/21/2016

Re: blue finch post# 185930

Wednesday, 03/20/2019 1:30:06 PM

Wednesday, March 20, 2019 1:30:06 PM

Post# of 458787

Excellent t
Thank you for your translation

Now we need a drug that works

Let’s see



IMO, we need to be able to connect the dots better. We have been trained in the past to react when the FDA or someone says they passed some milestone. When the science process is providing us w/way point information real time we need to read them. This is a process indicator read of facts which is a step up from speculation.

We have evidence that the PDD trials are filling up much faster than planned. We have information from AVXL that they are procuring additional A2-73 stock. Dr.M. volunteered that PDD trial patients are wearing validated medical devices( produced at an FDA licensed facility) to monitor sleep.

On the dot connection theory, is it possible/likely that the apparently accelerated (reported on Spanish news) PDD trial enlistment schedule is related to positive feedback from patients in trials. Good news is hard to come by in PDD community. So, people hear good news and are in a hurry to get signed up. IMO, this may be what we are witnessing. And TRUST ME, this kind of thing cuts both ways in technology driven, bad news travels even faster.

IMO, the system is telling us there is evidence A2-73 PDD works. When WS figures out how to read this kind of news it will get off the trial menu and get into the real world. But, many have still not figured out that the FDA has shat the CNS disease bed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News